Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation

Rationale: The role of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) in the development or progression of interstitial lung disease (ILD) is controversial. Objectives: To evaluate the association between statin use and ILD. Methods: We used regression analyses to evaluate the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Xu, Jin-Fu, Washko, George R., Nakahira, Kiichi, Hatabu, Hiroto, Patel, Avignat S., Fernandez, Isis E., Nishino, Mizuki, Okajima, Yuka, Yamashiro, Tsuneo, Ross, James C., San José Estépar, Raúl, Diaz, Alejandro A., Li, Hui-Ping, Qu, Jie-Ming, Himes, Blanca E., Come, Carolyn E., D'Aco, Katherine, Martinez, Fernando J., Han, MeiLan K., Lynch, David A., Crapo, James D., Morse, Danielle, Ryter, Stefan W., Silverman, Edwin K., Rosas, Ivan O., Choi, Augustine M. K., Hunninghake, Gary M.
Formato: Artigo
Idioma:Inglês
Publicado: American Thoracic Society 2012
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3297101/
https://ncbi.nlm.nih.gov/pubmed/22246178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1574OC
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares